| Net Cash Provided by (Used in) Operating Activities |
$32,850 |
USD |
-38% |
Q4 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$130,000 |
USD |
|
Q4 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
500,000,000 |
shares |
0% |
Q4 2025 |
Q1 2026 |
| Common Stock, Shares, Issued |
34,276,816 |
shares |
0% |
Q4 2025 |
Q1 2026 |
| Common Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q4 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$71,555 |
USD |
-6.1% |
Q4 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$60,487 |
USD |
56% |
Q3 2025 |
FY 2025 |
| Depreciation |
$0 |
USD |
|
Q4 2025 |
Q1 2026 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$60,487 |
USD |
56% |
Q3 2025 |
FY 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q4 2025 |
Q1 2026 |
| Preferred Stock, Shares Authorized |
50,000,000 |
shares |
900% |
Q4 2025 |
Q1 2026 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q4 2025 |
Q1 2026 |
| Additional Paid in Capital |
$5,494,739 |
USD |
9.5% |
Q4 2025 |
Q1 2026 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q4 2025 |
Q1 2026 |
| Interest Expense |
$10,500 |
USD |
0% |
Q4 2025 |
Q1 2026 |
| Preferred Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q4 2025 |
Q1 2026 |